Yuan et al. [22], in a meta-analysis of DNMT3A R882 mutations in AML patients consisting of eight studies with 4474 AML cases with 694 AML patients with DNMT3A R882 mutations, verified significantly reduced RFS and OS in AML patients with DNMT3A R882 mutations. Here, DNMT3A is linked to acute myeloid leukemia.